Yagci, M. Et Al. 2000. Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia.. American journal of hematology , vol.64, no.3 , 233-4.

Yagci, M., Sucak, G., & Haznedar, R., (2000). Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia.. American journal of hematology , vol.64, no.3, 233-4.

Yagci, ABDULLAH, GT Sucak, And R Haznedar. "Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia.," American journal of hematology , vol.64, no.3, 233-4, 2000

Yagci, ABDULLAH M. Et Al. "Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia.." American journal of hematology , vol.64, no.3, pp.233-4, 2000

Yagci, M. Sucak, G. And Haznedar, R. (2000) . "Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia.." American journal of hematology , vol.64, no.3, pp.233-4.

@article{article, author={ABDULLAH MÜNCİ YAĞCI Et Al. }, title={Fludarabine and risk of hepatitis B virus reactivation in chronic lymphocytic leukemia.}, journal={American journal of hematology}, year=2000, pages={233-4} }